30 July 2018
Visiongain’ has launched a new pharma report Global Electrosurgical Energy Devices Market Forecast 2018-2028: Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems, Bipolar Instruments, Monopolar Instruments, Patient Return Electrodes, Dispersive Electrodes, Cords, Cables and Adapters, General Surgery, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic, Neurosurgery
The electrosurgical energy devices market is driven by factors such as increasing geriatric population, increasing demand for minimally invasive surgeries, and the launch of technologically advanced electrosurgical energy devices. However, pitfalls such as stringent government regulations are restraining the market for electrosurgical energy devices.
By product type, electrosurgical instruments and accessories dominated the market in 2017 owing to the high use of instruments and accessories in different surgical procedures such as cosmetic surgery, neurosurgery, cardiovascular surgery, urologic surgery, general surgery and others.
The lead analyst of the report commented “The growth of the electrosurgical device market is estimated to be catalysed by opportunities in untapped, emerging markets with high potential due to improving healthcare infrastructure, unmet healthcare needs, rise in chronic diseases and increased demands for minimally invasive surgeries.
The healthcare industry in emerging economies is developing at a significant rate due to augmentation in demand for better healthcare services, significant investments to improve healthcare infrastructure and growth of medical tourism industry in emerging countries.”
Leading companies featured in the report include B. Braun Melsungen AG, Bovie Medical Corporation, Conmed, ERBE Elektromedizin GmbH , Johnson & Johnson, KLS Martin Group, Medtronic, Megadyne Medical Products, Inc., Olympus Corporation, Utah Medical Products, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
There is an increasing focus to identify diseases that currently do not have a vaccine.
20 June 2019
The market for ophthalmic drugs is a growing one.
17 June 2019
Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.
14 June 2019
The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.